NOVAVAX ($NVAX) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of -$0.51 per share, beating estimates of -$0.52 by $0.01. The company also reported revenue of $88,310,000, beating estimates of $86,067,600 by $2,242,400.
You can see Quiver Quantitative's $NVAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NOVAVAX Insider Trading Activity
NOVAVAX insiders have traded $NVAX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NVAX stock by insiders over the last 6 months:
- JAMES F YOUNG has made 0 purchases and 2 sales selling 10,000 shares for an estimated $82,208.
- RACHEL K. KING sold 4,150 shares for an estimated $37,435
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NOVAVAX Hedge Fund Activity
We have seen 103 institutional investors add shares of NOVAVAX stock to their portfolio, and 125 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 4,326,403 shares (+823.5%) to their portfolio in Q4 2024, for an estimated $34,784,280
- MORGAN STANLEY added 3,387,896 shares (+218.3%) to their portfolio in Q4 2024, for an estimated $27,238,683
- BANK OF MONTREAL /CAN/ removed 2,440,010 shares (-99.4%) from their portfolio in Q4 2024, for an estimated $19,617,680
- COATUE MANAGEMENT LLC removed 2,224,319 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $17,883,524
- DEEP TRACK CAPITAL, LP added 2,000,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $16,079,999
- SHAH CAPITAL MANAGEMENT added 1,333,305 shares (+13.6%) to their portfolio in Q4 2024, for an estimated $10,719,772
- TWO SIGMA ADVISERS, LP removed 1,219,700 shares (-61.0%) from their portfolio in Q4 2024, for an estimated $9,806,387
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
